Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Optimizing Use of Oral HIV PrEP

In this podcast, CCO’s expert faculty discusses approved and guideline-recommended oral HIV PrEP regimens and provides key insights on determining PrEP candidacy and important considerations for specific populations or clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.
Darrell H. S. Tan, MD, FRCPC, PhD
Released: August 12, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Gilead Sciences, Inc.

Related Content

Slides from CCO: Discussion of key data and recommendations for choosing ART regimens for older patients with renal impairment or liver disease.

Jonathan Appelbaum, MD, FACP, AAHIVS Jens D. Lundgren, MD, DMSc Released: January 13, 2022

From Clinical Care Options (CCO): Dr. Samantha Hill and Dr. David Malebranche on barriers to HIV testing, prevention, and treatment services in BIPOC communities and migrant populations in the US

person default Samantha V. Hill, MD, MPH David Malebranche, MD, MPH Released: January 12, 2022

Free slides from CCO featuring data on racial inequities in HIV care in BIPOC communities and strategies to combat racial disparities in HIV

person default Solange L. Baptiste, ScM Rageshri Dhairyawan, MBBS, BSc, FCRP, DipGUM, DipHIV, DFSRH person default Samantha V. Hill, MD, MPH David Malebranche, MD, MPH Released: January 11, 2022

Clinical Care Options (CCO) expert audio: Drs Daria Podlekareva and Mark Sulkowski discuss key data and recommendations for choosing ART regimens for patients who are coinfected with HBV/HIV and TB/HIV

person default Daria Podlekareva, MD, PhD Mark S. Sulkowski, MD Released: January 10, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings